Literature DB >> 1011075

A general method for optimal drug dose computation.

L A Wheeler, L B Sheiner.   

Abstract

Mesh:

Year:  1976        PMID: 1011075     DOI: 10.1007/bf01064554

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  8 in total

1.  Mathematical formulation for nonuniform multiple dosing.

Authors:  J R Howell
Journal:  J Pharm Sci       Date:  1975-03       Impact factor: 3.534

2.  Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations.

Authors:  L B Sheiner; H Halkin; C Peck; B Rosenberg; K L Melmon
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

3.  A safe method for rapidly achieving plasma concentration plateaus.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

4.  Pharmacokinetics of intravenous theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Drug input optimization: bioavailability-effected time-optimal control of multiple, simultaneous, pharmacological effects and their interrelationships.

Authors:  V F Smolen; B D Turrie; W A Weigand
Journal:  J Pharm Sci       Date:  1972-12       Impact factor: 3.534

6.  Reducation of digitalis toxicity by computer-assisted glycoside dosage regimens.

Authors:  R W Jelliffe; J Buell; R Kalaba
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

7.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

8.  Continuous intravenous infusion and multicompartment accumulation.

Authors:  E Krüger-Thiemer
Journal:  Eur J Pharmacol       Date:  1968-10       Impact factor: 4.432

  8 in total
  1 in total

1.  Rapid achievement of a serum concentration plateau of digoxin through controlled infusion.

Authors:  M Weiss; W Sziegoleit; A Fahr; W Förster
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.